Literature DB >> 2730277

Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset.

G W Small1, D E Kuhl, W H Riege, D G Fujikawa, J W Ashford, E J Metter, J C Mazziotta.   

Abstract

No previous study of Alzheimer's disease has, to our knowledge, assessed the effect of both age at dementia onset and gender on cerebral glucose metabolic patterns. To this end, we used positron emission tomography (fludeoxyglucose F 18 method) to study 24 patients with clinical diagnoses of probable Alzheimer's disease. Comparisons of the 13 patients with early-onset dementia (less than 65 years of age) with the 11 patients with late-onset dementia (greater than 65 years of age) revealed significantly lower left parietal metabolic ratios (left posterior parietal region divided by the hemispheric average) in the early-onset group. The metabolic ratio of posterior parietal cortex divided by the relatively disease-stable average of caudate and thalamus also separated patients with early-onset dementia from those with late-onset dementia, but not men from women. Further comparisons between sexes showed that, in all brain regions studied, the 9 postmenopausal women had higher nonweighted mean metabolic rates than the 15 men from the same age group, with hemispheric sex differences of 9% on the right and 7% on the left. These results demonstrate decreased parietal ratios in early-onset dementia of Alzheimer's disease, independent of a gender effect.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730277     DOI: 10.1001/archpsyc.1989.01810060047008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  11 in total

Review 1.  Molecular neuroimaging in Alzheimer's disease.

Authors:  William Jagust
Journal:  NeuroRx       Date:  2004-04

2.  Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer's disease.

Authors:  Natalie C Kaiser; Rebecca J Melrose; Collin Liu; David L Sultzer; Elvira Jimenez; Michael Su; Lorena Monserratt; Mario F Mendez
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-09-17       Impact factor: 2.035

3.  Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity.

Authors:  Yolanda R Smith; Luvina Bowen; Tiffany M Love; Alison Berent-Spillson; Kirk A Frey; Carol C Persad; Nancy K Reame; Robert A Koeppe; Jon-Kar Zubieta
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

4.  Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD.

Authors:  Daniel H S Silverman; Cheri L Geist; Heather A Kenna; Katherine Williams; Tonita Wroolie; Bevin Powers; John Brooks; Natalie L Rasgon
Journal:  Psychoneuroendocrinology       Date:  2010-09-01       Impact factor: 4.905

5.  Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease.

Authors:  E Salmon; F Collette; C Degueldre; C Lemaire; G Franck
Journal:  Hum Brain Mapp       Date:  2000-05       Impact factor: 5.038

6.  Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images.

Authors:  Kazunari Ishii; Takashi Kawachi; Hiroki Sasaki; Atsushi K Kono; Tetsuya Fukuda; Yoshio Kojima; Etsuro Mori
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

7.  Differences in regional cerebral blood flow patterns in male versus female patients with Alzheimer disease.

Authors:  Haruo Hanyu; Soichiro Shimizu; Yuriko Tanaka; Masaru Takasaki; Kiyoshi Koizumi; Kimihiko Abe
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

8.  Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction.

Authors:  Tyler G Demarest; Vijay R Varma; Darlene Estrada; Mansi Babbar; Sambuddha Basu; Uma V Mahajan; Ruin Moaddel; Deborah L Croteau; Madhav Thambisetty; Mark P Mattson; Vilhelm A Bohr
Journal:  Acta Neuropathol       Date:  2020-04-24       Impact factor: 17.088

Review 9.  Putative Survival Advantages in Young Apolipoprotein ɛ4 Carriers are Associated with Increased Neural Stress.

Authors:  Carr J Smith; J Wesson Ashford; Thomas A Perfetti
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

10.  Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer's disease: a prospective, open-label pilot study.

Authors:  Tohru Ohnuma; Aiko Toda; Ayako Kimoto; Yuto Takebayashi; Ryoko Higashiyama; Yuko Tagata; Masanobu Ito; Tsuneyoshi Ota; Nobuto Shibata; Heii Arai
Journal:  Clin Interv Aging       Date:  2016-01-08       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.